RxDoctor Payments Data

Luke Zurbriggen, MD

Hematology-Oncology · Madison, WINPI 1699161901

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

Too few hematology-oncology providers in Wisconsinto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,200,986
Medicare patients
405
Services billed
61,296

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JakafiRuxolitinib Phosphate32$532,856
LumakrasSotorasib24$514,088
Lenalidomide18$248,272
ImbruvicaIbrutinib11$75,087
EliquisApixaban35$30,069
Abiraterone Acetate17$21,526
Mycophenolate Mofetil28$18,488
Hydroxyurea61$1,583
Acyclovir140$1,507
Fluconazole19$838
Ondansetron Hcl46$536
Prednisone58$415
Dexamethasone30$399
Bicalutamide16$339
Prochlorperazine Maleate25$326

Paid to pharmacies, not to this prescriber.

Other hematology-oncology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →